A leading provider of
innovative DNA Screening solutions
IGH/CCND3 Translocation, Dual Fusion LPH040
Approximately 40-60% of multiple myeloma cases are associated with translocations involving the IgH locus. Cases lacking an IgH translocation are associated with hyperdiploid phenotype. The CCND3/IGH translocation t(6;14)(p12-p21;q32) has been reported in 3-4% of multiple myeloma tumours. However it is also characteristic of a variety of other B-cell malignancies including plasma cell leukaemia, diffuse large B-cell non-Hodgkin lymphoma (DLBCL) and splenic marginal zone lymphomas (SMZLs). Cyclin D3 has been identified as a putative oncogene that is dysregulated as the consequence of the translocation.
IGH/CCND3 Translocation, Dual Fusion
Cat. No. LPH 040-S (5 tests)
Cat. No. LPH 040 (10 tests)
This webpage could contain information on product details or information not valid in your country or region. Please be aware that we do not take any responsibility for accessing such information, which may not comply with any legal process, regulation, registration or usage in the country of your origin. If you are a resident of a country other than those to which this site is directed, contact your local Cytocell distributor to obtain the appropriate product information for your country of residence.
Developed &produced in the UK